Proshares Ultrashort Health Etf Current Valuation
| RXD Etf | USD 10.52 0.04 0.38% |
Valuation analysis of ProShares UltraShort helps investors to measure ProShares UltraShort's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that ProShares UltraShort's price fluctuation is not too volatile at this time. Calculation of the real value of ProShares UltraShort is based on 3 months time horizon. Increasing ProShares UltraShort's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ProShares etf is determined by what a typical buyer is willing to pay for full or partial control of ProShares UltraShort Health. Since ProShares UltraShort is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProShares Etf. However, ProShares UltraShort's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.52 | Real 9.73 | Hype 10.52 | Naive 10.06 |
The real value of ProShares Etf, also known as its intrinsic value, is the underlying worth of ProShares UltraShort ETF, which is reflected in its stock price. It is based on ProShares UltraShort's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ProShares UltraShort's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ProShares UltraShort Health helps investors to forecast how ProShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProShares UltraShort more accurately as focusing exclusively on ProShares UltraShort's fundamentals will not take into account other important factors: ProShares UltraShort Health ETF Current Valuation Analysis
ProShares UltraShort's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ProShares UltraShort Health has a Current Valuation of 0.0. This indicator is about the same for the ProShares average (which is currently at 0.0) family and about the same as Trading--Inverse Equity (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
ProShares Fundamentals
| Number Of Employees | 10 | |||
| Beta | -1.3 | |||
| Total Asset | 9.15 M | |||
| One Year Return | (15.20) % | |||
| Three Year Return | (6.60) % | |||
| Five Year Return | (20.80) % | |||
| Ten Year Return | (21.00) % | |||
| Net Asset | 9.15 M | |||
| Last Dividend Paid | 0.017 | |||
| Equity Positions Weight | (199.98) % |
About ProShares UltraShort Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProShares UltraShort Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProShares UltraShort using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProShares UltraShort Health based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ProShares UltraShort is a strong investment it is important to analyze ProShares UltraShort's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProShares UltraShort's future performance. For an informed investment choice regarding ProShares Etf, refer to the following important reports:Check out ProShares UltraShort Piotroski F Score and ProShares UltraShort Altman Z Score analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
The market value of ProShares UltraShort is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares UltraShort's value that differs from its market value or its book value, called intrinsic value, which is ProShares UltraShort's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares UltraShort's market value can be influenced by many factors that don't directly affect ProShares UltraShort's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares UltraShort's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares UltraShort is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares UltraShort's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.